Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06810427 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Novel, Low-Cost, Handheld 3D Imaging System for Improved Screening for Cervical Neoplasia in Resource-Limited Settings

Study acronym: CervImage
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study completion date: Jul 16, 2025 to Jul 31, 2026v3
  2. Trial status: Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Jul 16, 2025 to May 16, 2025
    • Site details revised
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluate the design and engineering of a new minimally invasive medical imaging device (CervImage™). Investigators are trying to find out if CervImage™ is reliable and easy to use to obtain clinical 3D photographs and to record 3D measurements in human cervixes. Investigators then plan to use these images to determine if CervImage™ design and engineering improvements need to be made.
Trial Details
NCT Number NCT06810427
Lead Sponsor Carilion Clinic
Collaborators: National Cancer Institute (NCI), Pensievision, Inc
Conditions
(from sponsor)		 Cervical Intraepithelial Neoplasia
Related terms Uterine Cervical Dysplasia
Enrollment 18 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov